BPA for xyrem, xywav

Active Awarded Last action

Contract number
36E79724A0028
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 73% complete
IDV ceiling
$161,183,457.45
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The Department of Veterans Affairs' National Acquisition Center established a single-award Blanket Purchase Agreement with Jazz Pharmaceuticals, Inc. on August 16, 2024, with a ceiling of $161,183,457.45 and an ultimate completion date of August 15, 2027.

The BPA is established against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and authorizes procurement of Xyrem (sodium oxybate) and Xywav (calcium/magnesium/potassium/sodium oxybate) for distribution to VA medical facilities. No set-aside was applied. Performance occurs across multiple Veterans Integrated Service Networks and locations throughout the United States, including Normandy and Palo Alto, California, and St. Louis, Missouri.

Delivery orders issued under this BPA have ranged from under $5,000 to over $900,000, with calls distributed across Veterans Integrated Service Networks 4, 5, 6, 20, and 21. The BPA enables rapid acquisition and distribution of these specialty sleep-disorder medications while maintaining pricing stability across VA healthcare operations.

Transactions

Action Obligated Date
Exercise an Option P00009 · Exercise option year 2 - BPA 36E79724A0028 $0
Supplemental Agreement for work within scope P00008 · This modification is issued to incorporate a price increase to 1 modeyso NDC on BPA 36E79724A0028. $0
Supplemental Agreement for work within scope P00007 · This modification is issued to incorporate a TPR to an existing xywav NDC on BPA 36E79724A0028. $0
Supplemental Agreement for work within scope P00006 · This modification is issued to incorporate the public law pricing update 2026. $0
Supplemental Agreement for work within scope P00005 · This modification is issued to incorporate the product deletion of 1 NDC to BPA 36E797240028. $0
Supplemental Agreement for work within scope P00004 · This modification is issued to incorporate the product addition of 1 NDC to BPA 36E797240028. $0
Exercise an Option P00003 · This modification is issued to exercise option year 1 on BPA 36E797240028. $0
Supplemental Agreement for work within scope P00002 · 2025 temporary price reduction (TPR). $0
Supplemental Agreement for work within scope P00001 · 2025 public law pricing updates. $0
Original award $0

Quick answers

Who was awarded contract 36E79724A0028?

36E79724A0028 was awarded to Jazz Pharmaceuticals, Inc. by National Acquisition Center (Headquarters) on August 16, 2024.

How much is contract 36E79724A0028 worth?

36E79724A0028's own ceiling is $161,183,457.

Who can order from contract 36E79724A0028?

36E79724A0028 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79724A0028 under another contract?

Yes. 36E79724A0028 is a blanket purchase agreement under 36F79719D0205, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79724A0028 competed?

The extent of competition for 36E79724A0028 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login